Vanda Pharmaceuticals
VNDA
#7861
Rank
ยฃ0.23 B
Marketcap
ยฃ4.04
Share price
3.65%
Change (1 day)
6.58%
Change (1 year)

Vanda Pharmaceuticals (VNDA) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.22 Billion

According to Vanda Pharmaceuticals's latest financial reports the company has ยฃ0.22 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.29 B-2.04%
2023-12-31ยฃ0.30 B-21.03%
2022-12-31ยฃ0.38 B20.35%
2021-12-31ยฃ0.32 B18.85%
2020-12-31ยฃ0.26 B13.34%
2019-12-31ยฃ0.23 B17.4%
2018-12-31ยฃ0.20 B91.07%
2017-12-31ยฃ0.10 B-7.36%
2016-12-31ยฃ0.11 B18.56%
2015-12-31ยฃ96.61 M15.87%
2014-12-31ยฃ83.38 M5.52%
2013-12-31ยฃ79.02 M6.08%
2012-12-31ยฃ74.49 M-22.23%
2011-12-31ยฃ95.78 M-25.33%
2010-12-31ยฃ0.12 B1.12%
2009-12-31ยฃ0.12 B300.22%
2008-12-31ยฃ31.69 M-26.06%
2007-12-31ยฃ42.87 M163.5%
2006-12-31ยฃ16.27 M-9.94%
2005-12-31ยฃ18.06 M113.31%
2004-12-31ยฃ8.46 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
ยฃ7.31 B 3,220.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ7.43 B 3,274.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.92 B 6,218.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.37 B 5,517.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.23 B 5,000.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
ยฃ2.1 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ13.66 B 6,100.47%๐Ÿ‡บ๐Ÿ‡ธ USA